Literature DB >> 20056174

Multi-functional P(3HB) microsphere/45S5 Bioglass-based composite scaffolds for bone tissue engineering.

Lydia Francis1, Decheng Meng, Jonathan C Knowles, Ipsita Roy, Aldo R Boccaccini.   

Abstract

Novel multi-functional P(3HB) microsphere/45S5 Bioglass-based composite scaffolds exhibiting potential for drug delivery were developed for bone tissue engineering. 45S5 Bioglass-based glass-ceramic scaffolds of high interconnected porosity produced using the foam-replication technique were coated with biodegradable microspheres (size<2 microm) made from poly(3-hydroxybutyrate), P(3HB), produced using Bacillus cereus SPV. A solid-in-oil-in-water emulsion solvent extraction/evaporation technique was used to produce these P(3HB) microspheres. A simple slurry-dipping method, using a 1 wt.% suspension of P(3HB) microspheres in water, dispersed by an ultrasonic bath, was used to coat the scaffold, producing a uniform microsphere coating throughout the three-dimensional scaffold structure. Compressive strength tests confirmed that the microsphere coating slightly enhanced the scaffold mechanical strength. It was also confirmed that the microsphere coating did not inhibit the bioactivity of the scaffold when immersed in simulated body fluid (SBF) for up to 4 weeks. The hydroxyapatite (HA) growth rate on P(3HB) microsphere-coated 45S5 Bioglass composite scaffolds was very similar to that on the uncoated control sample, qualitatively indicating similar bioactivity. However, the surface topography of the HA surface layer was affected as shown by results obtained from white light interferometry. The roughness of the surface was much higher for the P(3HB) microsphere-coated scaffolds than for the uncoated samples, after 7 days in SBF. This feature would facilitate cell attachment and proliferation. Finally, gentamycin was successfully encapsulated into the P(3HB) microspheres to demonstrate the drug delivery capability of the scaffolds. Gentamycin release kinetics was determined using liquid chromatography-mass spectrometry. The release of the drug from the coated composite scaffolds was slow and controlled when compared to the observed fast and relatively uncontrolled drug release from the bone scaffold (without microsphere coating). Thus, this unique multifunctional bioactive composite scaffold has the potential to enhance cell attachment and to provide controlled delivery of relevant drugs for bone tissue engineering. Copyright 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20056174     DOI: 10.1016/j.actbio.2009.12.054

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  15 in total

1.  Calcium phosphate deposition rate, structure and osteoconductivity on electrospun poly(l-lactic acid) matrix using electrodeposition or simulated body fluid incubation.

Authors:  Chuanglong He; Xiaobing Jin; Peter X Ma
Journal:  Acta Biomater       Date:  2013-09-05       Impact factor: 8.947

Review 2.  Biomaterials advances in patches for congenital heart defect repair.

Authors:  Seokwon Pok; Jeffrey G Jacot
Journal:  J Cardiovasc Transl Res       Date:  2011-06-07       Impact factor: 4.132

3.  Effect of heat treatment on the properties of SiO2-CaO-MgO-P 2O 5 bioactive glasses.

Authors:  Yue Zhou; Hongying Li; Kaili Lin; Wanying Zhai; Weiming Gu; Jiang Chang
Journal:  J Mater Sci Mater Med       Date:  2012-06-15       Impact factor: 3.896

4.  Low-power ultrasounds as a tool to culture human osteoblasts inside cancellous hydroxyapatite.

Authors:  Lorenzo Fassina; Enrica Saino; Maria Gabriella Cusella De Angelis; Giovanni Magenes; Francesco Benazzo; Livia Visai
Journal:  Bioinorg Chem Appl       Date:  2010-03-31       Impact factor: 7.778

Review 5.  Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspects.

Authors:  Heidi M Mansour; Minji Sohn; Abeer Al-Ghananeem; Patrick P Deluca
Journal:  Int J Mol Sci       Date:  2010-09-15       Impact factor: 5.923

6.  Tetracycline-encapsulated P(3HB) microsphere-coated 45S5 Bioglass(®)-based scaffolds for bone tissue engineering.

Authors:  D Meng; L Francis; I D Thompson; C Mierke; H Huebner; A Amtmann; I Roy; A R Boccaccini
Journal:  J Mater Sci Mater Med       Date:  2013-07-28       Impact factor: 3.896

7.  Controlled delivery of gentamicin using poly(3-hydroxybutyrate) microspheres.

Authors:  Lydia Francis; Decheng Meng; Jonathan Knowles; Tajalli Keshavarz; Aldo R Boccaccini; Ipsita Roy
Journal:  Int J Mol Sci       Date:  2011-07-04       Impact factor: 5.923

8.  Investigating the Vascularization of Tissue-Engineered Bone Constructs Using Dental Pulp Cells and 45S5 Bioglass® Scaffolds.

Authors:  Reem El-Gendy; Jennifer Kirkham; Phillipa J Newby; Yamuna Mohanram; Aldo Roberto Boccaccini; Xuebin B Yang
Journal:  Tissue Eng Part A       Date:  2015-04-29       Impact factor: 3.845

9.  Successful human long-term application of in situ bone tissue engineering.

Authors:  Raymund E Horch; Justus P Beier; Ulrich Kneser; Andreas Arkudas
Journal:  J Cell Mol Med       Date:  2014-05-06       Impact factor: 5.310

10.  Enhanced osteogenicity of bioactive composites with biomimetic treatment.

Authors:  Ville V Meretoja; Teemu Tirri; Minna Malin; Jukka V Seppälä; Timo O Närhi
Journal:  Biomed Res Int       Date:  2014-04-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.